72 related articles for article (PubMed ID: 178987)
1. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
Mühlfellner G; Mühlfellner O; Kaffarnik H
Med Klin; 1976 Apr; 71(18):775-8. PubMed ID: 178987
[TBL] [Abstract][Full Text] [Related]
2. [Dose-effect of beta-sitosterin in type IIa and IIb hypercholesterolemias (author's transl)].
Schwartzkopff W; Jantke HJ
MMW Munch Med Wochenschr; 1978 Nov; 120(47):1575-8. PubMed ID: 214701
[TBL] [Abstract][Full Text] [Related]
3. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
4. [Beta-sitosterin in the treatment of essential type II hyperlipoproteinemias].
Kaffarnik H; Mühlfellner G; Mühlfellner O; Schneider J; Hausmann L; Zöfel P; Schubotz R; Fuchs F
Fortschr Med; 1977 Dec; 95(46):2785-7. PubMed ID: 590905
[TBL] [Abstract][Full Text] [Related]
5. [Sitosterol in familial hyperlipoproteinemia type II. A randomized double-blind cross-over study].
Oster P; Schlierf G; Heuck CC; Greten H; Gundert-Remy U; Haase W; Klose G; Nothelfer A; Raetzer H; Schellenberg B; Schmidt-Gayk H
Dtsch Med Wochenschr; 1976 Sep; 101(36):1308-11. PubMed ID: 182445
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
Haacke H; Parwaresch MR; Mäder C
Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
[TBL] [Abstract][Full Text] [Related]
7. Sitosterol in juvenile type II hyperlipoproteinemia.
Schlierf G; Oster P; Heuck CC; Raetzer H; Schellenberg B
Atherosclerosis; 1978 Aug; 30(4):245-8. PubMed ID: 213081
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
Klemens UH; von Löwis P
Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of cinnarizine in hyperlipaemic patients.
Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
[No Abstract] [Full Text] [Related]
10. Serum lipoproteins and lecithin: cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol.
Weisweiler P; Heinemann V; Schwandt P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):204-6. PubMed ID: 6715090
[TBL] [Abstract][Full Text] [Related]
11. [Hypolipidemic action of beta-D-glycoside beta-sitosterol in the rat].
Mironova VN; Kalashnikova LA
Farmakol Toksikol; 1982; 45(6):45-7. PubMed ID: 7151999
[TBL] [Abstract][Full Text] [Related]
12. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
Millett F; Sielski J; Stoll H; Alston N; Gail S
PA J; 1976; 6(2):54-9. PubMed ID: 10235781
[No Abstract] [Full Text] [Related]
14. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Witztum JL; Schonfeld G; Weidman SW
J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
17. Comparative treatment of hyperlipoproteinaemias in chimpanzees.
Vastesaeger M; Blaton V; Declercq B; Vercruysse J; Vandamme D; Peeters H; Mortelmans J
Acta Zool Pathol Antverp; 1974; 58(0):79-96. PubMed ID: 4365833
[No Abstract] [Full Text] [Related]
18. Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia.
Wülfert B; Majoie B; de Ceaurriz A
Arzneimittelforschung; 1976; 26(5):906-9. PubMed ID: 183789
[TBL] [Abstract][Full Text] [Related]
19. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
20. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
Einarsson K; Hellström K; Leijd B
J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
